Results 201 to 210 of about 2,750,739 (393)

Researchers, Patients and Open Access Publishing [PDF]

open access: yes, 2016
Participatory healthcare is a model of self management characterised by emphasis on people living with long term conditions being seen as equal partners in their own care.
Bond, Carol S., Davey, Jill
core  

Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo

open access: yesMolecular Oncology, Volume 19, Issue 4, Page 1029-1053, April 2025.
Advanced tumors and ineffective cancer treatments can lead to metastases in distant organs. The sole expression of microRNA 200c (miR‐200c) in breast cancer cells is shown to significantly reduce metastasis formation in xenograft mouse models. Various in vitro analyses revealed impeded migratory behavior, upon miR‐200c expression, as one prerequisite ...
Bianca Köhler   +12 more
wiley   +1 more source

Putting the spotlight on CRISPR

open access: yesBioTechniques, 2019
Francesca Lake
doaj   +1 more source

Diamond Open Access Landscape in Croatia: DIAMAS Survey Results

open access: yesPublications
As open science initiatives address the crisis in scholarly communication driven by commercialisation, diamond open access publishing—promoting equity for authors and readers—has emerged as a focal point in open access scholarly publishing.
Jadranka Stojanovski, Danijel Mofardin
doaj   +1 more source

Open access to scientific publications: ideas and problems [PDF]

open access: yes
Open access scholarly publishing did not have yet a serious impact on the slow-moving world of research. Neither could it solve the serials crisis.
Koltay, Tibor
core   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy